Tumor suppressor role of the CL2/DRO1/CCDC80 gene in thyroid carcinogenesis

Angelo Ferraro, Filippo Schepis, Vincenza Leone, Antonella Federico, Eleonora Borbone, Pierlorenzo Pallante, Maria Teresa Berlingieri, Gennaro Chiappetta, Mario Monaco, Dario Palmieri, Lorenzo Chiariotti, Massimo Santoro, Alfredo Fusco

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Context: Thyroid carcinoma is one of the mostcommonmalignancies of the endocrine system, and, despite the high frequency of oncogene activation in thyroid neoplastic lesions, the tumor suppressor genes involved in thyroid carcinogenesis remain unidentified.Ourprevious data implicated a link between the CL2/CCDC80 gene and thyroid cancer. Objective: The objective of the study was to examine the expression of the CL2/CCDC80 gene in human thyroid carcinomas in the attempt to determine whether it plays a role in thyroid carcinogenesis. Design: Weevaluated the expression of CL2/CCDC80 in a large number of thyroid neoplastic tissue samples differing in degree of malignancy. We also investigated the effects of its restoration in 2 human thyroid carcinoma cell lines characterized by very low levels of CL2/CCDC80 expression. Results: CL2/CCDC80 expression was much lower in almost all the thyroid carcinomas analyzed than in normal thyroid tissues and was lowest in follicular variants of papillary carcinomas. Loss of heterozygosity partially accounted for CL2/CCDC80 down-regulation in thyroid carcinoma samples. Restoration of CL2/CCDC80 expression in the 2 human thyroid anaplastic carcinoma cell lines resulted in a higher susceptibility to apoptosis and suppression of the malignant phenotype. CL2/CCDC80 expression positively regulated the expression of E-cadherin, thereby halting cancer progression. Conclusions: These results indicate that CL2/CCDC80 is a putative tumor suppressor gene in thyroid carcinogenesis.

Original languageEnglish
Pages (from-to)2834-2843
Number of pages10
JournalJournal of Clinical Endocrinology and Metabolism
Volume98
Issue number7
DOIs
Publication statusPublished - Jul 2013

Fingerprint

Thyroid Neoplasms
Tumors
Thyroid Gland
Carcinogenesis
Genes
Restoration
Neoplasms
Cells
Tissue
Tumor Suppressor Genes
Cadherins
Carcinoma, Papillary, Follicular
Cell Line
Endocrine System
Loss of Heterozygosity
Chemical activation
Apoptosis
Oncogenes
Down-Regulation
Phenotype

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism

Cite this

Ferraro, A., Schepis, F., Leone, V., Federico, A., Borbone, E., Pallante, P., ... Fusco, A. (2013). Tumor suppressor role of the CL2/DRO1/CCDC80 gene in thyroid carcinogenesis. Journal of Clinical Endocrinology and Metabolism, 98(7), 2834-2843. https://doi.org/10.1210/jc.2012-2926

Tumor suppressor role of the CL2/DRO1/CCDC80 gene in thyroid carcinogenesis. / Ferraro, Angelo; Schepis, Filippo; Leone, Vincenza; Federico, Antonella; Borbone, Eleonora; Pallante, Pierlorenzo; Berlingieri, Maria Teresa; Chiappetta, Gennaro; Monaco, Mario; Palmieri, Dario; Chiariotti, Lorenzo; Santoro, Massimo; Fusco, Alfredo.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 98, No. 7, 07.2013, p. 2834-2843.

Research output: Contribution to journalArticle

Ferraro, A, Schepis, F, Leone, V, Federico, A, Borbone, E, Pallante, P, Berlingieri, MT, Chiappetta, G, Monaco, M, Palmieri, D, Chiariotti, L, Santoro, M & Fusco, A 2013, 'Tumor suppressor role of the CL2/DRO1/CCDC80 gene in thyroid carcinogenesis', Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 7, pp. 2834-2843. https://doi.org/10.1210/jc.2012-2926
Ferraro, Angelo ; Schepis, Filippo ; Leone, Vincenza ; Federico, Antonella ; Borbone, Eleonora ; Pallante, Pierlorenzo ; Berlingieri, Maria Teresa ; Chiappetta, Gennaro ; Monaco, Mario ; Palmieri, Dario ; Chiariotti, Lorenzo ; Santoro, Massimo ; Fusco, Alfredo. / Tumor suppressor role of the CL2/DRO1/CCDC80 gene in thyroid carcinogenesis. In: Journal of Clinical Endocrinology and Metabolism. 2013 ; Vol. 98, No. 7. pp. 2834-2843.
@article{5ceddd237f76438c89b00876d6c472ec,
title = "Tumor suppressor role of the CL2/DRO1/CCDC80 gene in thyroid carcinogenesis",
abstract = "Context: Thyroid carcinoma is one of the mostcommonmalignancies of the endocrine system, and, despite the high frequency of oncogene activation in thyroid neoplastic lesions, the tumor suppressor genes involved in thyroid carcinogenesis remain unidentified.Ourprevious data implicated a link between the CL2/CCDC80 gene and thyroid cancer. Objective: The objective of the study was to examine the expression of the CL2/CCDC80 gene in human thyroid carcinomas in the attempt to determine whether it plays a role in thyroid carcinogenesis. Design: Weevaluated the expression of CL2/CCDC80 in a large number of thyroid neoplastic tissue samples differing in degree of malignancy. We also investigated the effects of its restoration in 2 human thyroid carcinoma cell lines characterized by very low levels of CL2/CCDC80 expression. Results: CL2/CCDC80 expression was much lower in almost all the thyroid carcinomas analyzed than in normal thyroid tissues and was lowest in follicular variants of papillary carcinomas. Loss of heterozygosity partially accounted for CL2/CCDC80 down-regulation in thyroid carcinoma samples. Restoration of CL2/CCDC80 expression in the 2 human thyroid anaplastic carcinoma cell lines resulted in a higher susceptibility to apoptosis and suppression of the malignant phenotype. CL2/CCDC80 expression positively regulated the expression of E-cadherin, thereby halting cancer progression. Conclusions: These results indicate that CL2/CCDC80 is a putative tumor suppressor gene in thyroid carcinogenesis.",
author = "Angelo Ferraro and Filippo Schepis and Vincenza Leone and Antonella Federico and Eleonora Borbone and Pierlorenzo Pallante and Berlingieri, {Maria Teresa} and Gennaro Chiappetta and Mario Monaco and Dario Palmieri and Lorenzo Chiariotti and Massimo Santoro and Alfredo Fusco",
year = "2013",
month = "7",
doi = "10.1210/jc.2012-2926",
language = "English",
volume = "98",
pages = "2834--2843",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "7",

}

TY - JOUR

T1 - Tumor suppressor role of the CL2/DRO1/CCDC80 gene in thyroid carcinogenesis

AU - Ferraro, Angelo

AU - Schepis, Filippo

AU - Leone, Vincenza

AU - Federico, Antonella

AU - Borbone, Eleonora

AU - Pallante, Pierlorenzo

AU - Berlingieri, Maria Teresa

AU - Chiappetta, Gennaro

AU - Monaco, Mario

AU - Palmieri, Dario

AU - Chiariotti, Lorenzo

AU - Santoro, Massimo

AU - Fusco, Alfredo

PY - 2013/7

Y1 - 2013/7

N2 - Context: Thyroid carcinoma is one of the mostcommonmalignancies of the endocrine system, and, despite the high frequency of oncogene activation in thyroid neoplastic lesions, the tumor suppressor genes involved in thyroid carcinogenesis remain unidentified.Ourprevious data implicated a link between the CL2/CCDC80 gene and thyroid cancer. Objective: The objective of the study was to examine the expression of the CL2/CCDC80 gene in human thyroid carcinomas in the attempt to determine whether it plays a role in thyroid carcinogenesis. Design: Weevaluated the expression of CL2/CCDC80 in a large number of thyroid neoplastic tissue samples differing in degree of malignancy. We also investigated the effects of its restoration in 2 human thyroid carcinoma cell lines characterized by very low levels of CL2/CCDC80 expression. Results: CL2/CCDC80 expression was much lower in almost all the thyroid carcinomas analyzed than in normal thyroid tissues and was lowest in follicular variants of papillary carcinomas. Loss of heterozygosity partially accounted for CL2/CCDC80 down-regulation in thyroid carcinoma samples. Restoration of CL2/CCDC80 expression in the 2 human thyroid anaplastic carcinoma cell lines resulted in a higher susceptibility to apoptosis and suppression of the malignant phenotype. CL2/CCDC80 expression positively regulated the expression of E-cadherin, thereby halting cancer progression. Conclusions: These results indicate that CL2/CCDC80 is a putative tumor suppressor gene in thyroid carcinogenesis.

AB - Context: Thyroid carcinoma is one of the mostcommonmalignancies of the endocrine system, and, despite the high frequency of oncogene activation in thyroid neoplastic lesions, the tumor suppressor genes involved in thyroid carcinogenesis remain unidentified.Ourprevious data implicated a link between the CL2/CCDC80 gene and thyroid cancer. Objective: The objective of the study was to examine the expression of the CL2/CCDC80 gene in human thyroid carcinomas in the attempt to determine whether it plays a role in thyroid carcinogenesis. Design: Weevaluated the expression of CL2/CCDC80 in a large number of thyroid neoplastic tissue samples differing in degree of malignancy. We also investigated the effects of its restoration in 2 human thyroid carcinoma cell lines characterized by very low levels of CL2/CCDC80 expression. Results: CL2/CCDC80 expression was much lower in almost all the thyroid carcinomas analyzed than in normal thyroid tissues and was lowest in follicular variants of papillary carcinomas. Loss of heterozygosity partially accounted for CL2/CCDC80 down-regulation in thyroid carcinoma samples. Restoration of CL2/CCDC80 expression in the 2 human thyroid anaplastic carcinoma cell lines resulted in a higher susceptibility to apoptosis and suppression of the malignant phenotype. CL2/CCDC80 expression positively regulated the expression of E-cadherin, thereby halting cancer progression. Conclusions: These results indicate that CL2/CCDC80 is a putative tumor suppressor gene in thyroid carcinogenesis.

UR - http://www.scopus.com/inward/record.url?scp=84879967532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879967532&partnerID=8YFLogxK

U2 - 10.1210/jc.2012-2926

DO - 10.1210/jc.2012-2926

M3 - Article

VL - 98

SP - 2834

EP - 2843

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 7

ER -